» Articles » PMID: 22493095

Dynamically Regulated Sumoylation of HDAC2 Controls P53 Deacetylation and Restricts Apoptosis Following Genotoxic Stress

Overview
Journal J Mol Cell Biol
Specialty Molecular Biology
Date 2012 Apr 12
PMID 22493095
Citations 40
Authors
Affiliations
Soon will be listed here.
Abstract

Histone deacetylase 2 (HDAC2) is relevant for homeostasis and plays a critical role in gastrointestinal cancers. Here, we report that post-translational modification of endogenous HDAC2 with small ubiquitin-related modifier 1 (SUMO1) is a new regulatory switch for the tumor suppressor p53. Sumoylation of HDAC2 at lysine 462 allows binding of HDAC2 to p53. Moreover, sumoylated HDAC2 is a previously not recognized biologically relevant site-specific deacetylase for p53. Deacetylation of p53 at lysine 320 by sumoylated HDAC2 blocks recruitment of p53 into promoter-associated complexes and p53-dependent expression of genes for cell cycle control and apoptosis. Thereby, catalytically active sumoylated HDAC2 restricts p53 functions and attenuates DNA damage-induced apoptosis. Genotoxic stress evokes desumoylation of HDAC2, enabling p53-dependent gene expression. Our data show a new molecular mechanism involving a dynamically controlled HDAC2-sumoylation/p53-acetylation switch that regulates cell fate decisions following genotoxic stress.

Citing Articles

The role of acetylation and deacetylation in cancer metabolism.

Wang C, Ma X Clin Transl Med. 2025; 15(1):e70145.

PMID: 39778006 PMC: 11706801. DOI: 10.1002/ctm2.70145.


MDM2 Antagonist Idasanutlin Reduces HDAC1/2 Abundance and Corepressor Partners but Not HDAC3.

Smalley J, Cowley S, Hodgkinson J ACS Med Chem Lett. 2024; 15(1):93-98.

PMID: 38229760 PMC: 10788946. DOI: 10.1021/acsmedchemlett.3c00449.


Regulation of SUMOylation on RNA metabolism in cancers.

Cao Y, Huang C, Zhao X, Yu J Front Mol Biosci. 2023; 10:1137215.

PMID: 36911524 PMC: 9998694. DOI: 10.3389/fmolb.2023.1137215.


Dual activity inhibition of threonine aspartase 1 by a single bisphosphate ligand.

Hoing A, Struth R, Beuck C, Rafieiolhosseini N, Hoffmann D, Stauber R RSC Adv. 2022; 12(53):34176-34184.

PMID: 36545626 PMC: 9709806. DOI: 10.1039/d2ra06019a.


Insights into Regulators of p53 Acetylation.

Nagasaka M, Miyajima C, Aoki H, Aoyama M, Morishita D, Inoue Y Cells. 2022; 11(23).

PMID: 36497084 PMC: 9737083. DOI: 10.3390/cells11233825.